Preliminary identification of endometrial cancer stem cells in vitro and in vivo

Biochem Biophys Res Commun. 2017 Aug 19;490(2):506-513. doi: 10.1016/j.bbrc.2017.06.070. Epub 2017 Jun 15.

Abstract

Stem cells play a critical role in endometrial cancer progression. However, the current methodologies used to isolate endometrial cancer stem cells (ECSCs) remain unsatisfactory. The ECSCs were isolated by serumfree suspension cultivation. The stem cells-related genes CD44, CD133, Oct4, Sox2 and Nanog were analyzed, and the biological behaviour of ECSCs was evaluated in vitro and vivo. The results suggest that (i) serumfree suspension cultivation is non-toxic and a convenient way for isolating the ECSCs, and is not limited to specific surface markers; (ii) Ishikawa cells can be used as an effective source of ECSCs, and the obtained ECSCs expressing the pluripotent stem cells markers CD44, CD133, Oct4, Sox2, and Nanog; (iii) ECSCs originated from Ishikawa cells showed an increased ability to invasion and metastasis in vitro, and exhibited a high proliferative capacity and pluripotency in vivo and vitro. These findings indicate that serumfree suspension cultivation is an effective method for isolating ECSCs from Ishikawa cells, and the obtained ECSCs are tumorigenic and display stem cell-like properties.

Keywords: CD44(+)/CD133(+); Cancer stem cell; Endometrial cancer; Serum-free medium; Suspension cultivation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AC133 Antigen / analysis
  • Animals
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Cell Separation
  • Cell Survival
  • Endometrial Neoplasms / pathology*
  • Endometrium / cytology
  • Endometrium / pathology*
  • Female
  • Humans
  • Hyaluronan Receptors / analysis
  • Mice, Inbred BALB C
  • Neoplastic Stem Cells / cytology
  • Neoplastic Stem Cells / pathology*
  • Pluripotent Stem Cells / cytology
  • Pluripotent Stem Cells / pathology

Substances

  • AC133 Antigen
  • Hyaluronan Receptors